Nanorobots Seek Human Blood Cells
Columbia University College of Physicians & Surgeons | YouTube Channel
Watch the Animation: A molecular robot (automaton) in action. To tag cells (grey circle) that display the Mi, Mj, and Mk receptors, five different components of a molecular robot are deployed. Each of the first three components consists of DNA and an antibody; one antibody binds to each receptor, bringing its DNA (represented by the colored lines) close together on the cell. The fourth DNA component, represented by the single red line, then initiates a chain reaction by pulling the red DNA strand away from the first antibody. That causes the blue DNA strand to change position, followed by the green DNA strand. In the final step, the last antibody pulls a fluorescent DNA strand (labeled F) from the fifth component, completing the action of the robot. Image: Milan Stojanovic.
Researchers at Columbia University Medical Center, working with their collaborators at the Hospital for Special Surgery, have created a fleet of molecular “robots” that can home in on specific human cells and mark them for drug therapy or destruction.
The nanorobots—a collection of DNA molecules, some attached to antibodies—were designed to seek a specific set of human blood cells and attach a fluorescent tag to the cell surfaces.
“This opens up the possibility of using such molecules to target, treat, or kill specific cells without affecting similar healthy cells,” said the study’s senior investigator, Milan Stojanovic, PhD, associate professor of medicine and of biomedical engineering at Columbia University Medical Center.
Though other DNA nanorobots have been designed to deliver drugs to cells, the advantage of Stojanovic’s fleet is its ability to distinguish cell populations that do not share a single distinctive feature.
Drugs can be designed to target cancer cells with a specific receptor, but healthy cells with the same receptor will also be targeted. The only way to target cells more precisely is to identify cells based on a collection of features.
Large cell-sorting machines have the ability to identify cells based on multiple proteins, but until now, molecular therapeutics have not had that capability.
Dr. Stojanovic and his colleaguess ... approach is based on multiple simple molecules, which together form a robot (or automaton, as the authors prefer calling it).
To identify a cell possessing three specific surface proteins, Dr. Stojanovic first constructed three different components for molecular robots. Each component consisted of a piece of double-stranded DNA attached to an antibody specific to one of the surface proteins. When these components are added to a collection of cells, the antibody portions of the robot bind to their respective proteins (in the figure, CD45, CD3, and CD8) and work in concert ...
Read the whole story at Columbia University Medical Center...